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a b s t r a c t
The consequences of a mild traumatic brain injury can be especially severe if it is
repeated within the period of increased cerebral vulnerability (ICV) that follows the ini-
tial insult. To better understand the molecular mechanisms that contribute to ICV, we
exposed rats to different levels of mild blast overpressure (5 exposures; total pressure
range: 15.54–19.41psi or 107.14–133.83kPa) at a rate of 1 per 30min, monitored select
physiological parameters, and assessed behavior. Two days post-injury or sham, we deter-
mined changes in protein biomarkers related to various pathologies in behaviorally relevant
brain regions and in plasma. We found that oxygen saturation and heart rate were tran-
siently depressed following mild blast exposure and that injured rats exhibited signiﬁcantly
increased anxiety- and depression-related behaviors. Proteomic analyses of the selectedProtein biomarkers
Traumatic brain injury
brain regions showed evidence of substantial oxidative stress and vascular changes, altered
cell adhesion, and inﬂammation predominantly in the prefrontal cortex. Importantly, these
pathological changes as well as indications of neuronal and glial cell loss/damage were
also detected in the plasma of injured rats. Our ﬁndings illustrate some of the complex
molecular changes that contribute to the period of ICV in repeated mild blast-induced
traumatic brain injury. Further studies are needed to determine the functional and temporal
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ICV, increased cerebral vulnerability; mTBI, mild traumatic brain injury; OF, open ﬁeld; PFC, prefrontal cortex; PTSD, post-traumatic stress
disorder; rmTBI, repeated mild traumatic brain injury; TBI, traumatic brain injury; USU, Uniformed Services University; VHC, ventral
hippocampus.
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relationship between the various pathomechanisms. The validation of these and other
markers can help to diagnose individuals with ICV using a minimally invasive procedure
and to develop evidence-based treatments for chronic neuropsychiatric conditions.
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. Introduction
ild traumatic brain injuries (mTBIs) constitute approx-
mately 80% of all traumatic brain injuries (TBIs) [1].
mong civilians, mTBIs (better known as concussions)
ffect ∼1.3 million individuals in the US annually, mostly
uring contact sports such as boxing, hockey, and foot-
all [1,2]. In the military, ∼266,000 service members
uffered mTBIs between the years 2000 and 2012 with
he overwhelming majority of injuries being blast-induced
http://www.dvbic.org/dod-worldwide-numbers-tbi). Because
TBIs typically result in transient and very mild symptoms,
any injured individuals return to the same activity—sports
nd/or military duty—and signiﬁcant numbers are re-injured,
ome multiple times causing repeated mild TBI (rmTBI).
A single mTBI can result in neurobehavioral problems
uch as increased anxiety and cognitive impairment, but the
robability of short- as well as long-term impairment is sig-
iﬁcantly higher following rmTBI [3]. The exposure to a single
TBI triggers a complex cascade of pathological (as well
s restorative) responses during what is known as the sec-
ndary injury process. Depending on the severity of the insult,
ome or most of these changes dissipate over time especially
fter mTBIs. However, re-injury during the ongoing secondary
njury process can result in a disproportionally severe—even
atal—outcome and signiﬁcantly increase the probability of
ong-term damage. While severe TBIs have unique symptoms
early malignant cerebral edema and delayed severe vasocon-
triction), mTBI, symptoms and likely the components of its
econdary injury process are sharedwith other formsof closed
ead TBIs. However, one important unknown is whether the
nset and extent of the individual pathologies are shared
mong the different forms of mTBIs.
Clinical and experimental data have demonstrated that
he interval between insults is a key factor in determining
utcome severity after rmTBIs [4,5]. The interval after the ini-
ial insult during which re-injury causes disproportionately
dverse effects is referred to as the period of increased cere-
ral vulnerability (ICV). While the exact pathomechanism of
CV is currently unknown, two key studies using different
odels of rmTBI have shown that decreased cerebral glucose
etabolism and increased axonal and vascular vulnerability
re major contributors to ICV [6–8]. The authors have con-
luded that these otherwise transient changes predispose the
rain for additional damage if subsequent insults take place
ithin the period of ICV. Whether or not other components of
he secondary injury process contribute to ICV as well as the
xact “window period” of vulnerability have yet to be deter-
ined [5,9].
Previous studies, including our own, have identiﬁed sev-
ral of the pathobiologies involved in blast-induced TBI (bTBI),
hich may contribute to ICV. These include oxidative stress,
etabolic and vascular changes, altered cellular adhesion,uthors. Published by Elsevier B.V.
inﬂammation, as well as axonal, neuronal and glial cell dam-
age [10,11]. Accordingly, we have selected protein biomarkers
that are representative of the various functional clusters
listed above and assayed them using reverse phase protein
microarray (RPPM). While we have successfully utilized RPPM
for the identiﬁcation of blast-induced changes in brain tis-
sue, cerebrospinal ﬂuid, plasma and/or serum [10,12–16], the
method does not provide absolute protein values like other
antibody-based assays (e.g., ELISA) and its use is limited to
the availability of speciﬁc antibodies. However, RPPM offers
superior sensitivity, speciﬁcity, a dynamic range, and high
throughput ideal for assaying large numbers of samples.
Our previous works using the rodent model of bTBI identi-
ﬁed some of the functional deﬁcits sustained following single
and repeated mild blast overpressure exposure as well as sev-
eral of the molecular and cellular changes associated with
each type of injury [11].We found thatwhen ratswere exposed
to mild blast overpressure (∼138kPa) once per day for ﬁve con-
secutive days, the resultant damage (as indicated by speciﬁc
protein biomarker levels in the plasma and in brain tissue)
was only moderately greater in multiple blast-injured rats
compared to single-injured rats at 2h post-injury, 22 days, or
even 42 days after the injury. Consistent with the observations
from the abovementioned studies, our data indicated that the
period of ICV after blast-induced mTBI is considerably shorter
than 24h in rats.
To better understand the biology of ICV, in this study
we exposed rats to a total of ﬁve mild blasts at the
rate of 1 per 30min. As described herein, this increased
frequency/shortened interval of insults resulted in signiﬁ-
cant alterations in physiological parameters, neurobehavioral
deﬁcits, and extensivemolecular changes that can be detected
in functionally relevant brain regions as well as in circulating
blood. The detected changes in protein biomarker levels impli-
cate oxidative stress, vascular pathologies, and inﬂammation
in the cerebral vulnerability that follows blast-induced mTBI.
These markers can be tested in humans who have suffered an
mTBI and if validated they will aid in identifying individuals
with ICV and in determining a “safe return to duty/play”.
2. Materials and methods
2.1. Animals
A total of 22 male Sprague Dawley rats (weight at arrival:
280–300 g; approximate age in days: 63–67) (Charles River Labo-
ratories,Wilmington,MA)were used in our study. Upon arrival
at the Uniformed Services University (USU; Bethesda, MD),
animalswere housed in pairs in standard rat cages in a reverse
 
Open access under CC BY-NC-ND license.12h-light 12h-dark cycle with food and water ad lib. During
the 5-day acclimation period, animals were handled for 5min
each day prior to undergoing baseline physiological monitor-
ing and behavioral testing. Baseline horizontal activity results
teom24 translat ional pro
were used to create the experimental groups: naïve (n=4),
sham (n=6), and injured (n=12)with no statistical signiﬁcance
among them. Animals were handled according to protocol,
approved by the Institutional Animal Care andUse Committee
at USU.
2.2. Experimental manipulations and injury
For the duration of the study, naïve animals were kept in
the animal facility at USU without any manipulation except
on physiological monitoring and behavioral testing days as
described later. On the day of the injury, animals in the sham
and injured groups were transported from USU to Walter Reed
Army Institute of Research (Silver Spring, MD). Sham ratswere
anesthetized for 6min in an induction chamberwith 4% isoﬂu-
rane (Forane; Baxter Healthcare Corporation, Deerﬁeld, IL) and
placed into a shock tube holder in a transverse prone position
without being exposed to blast overpressure. Sham rats were
kept in the procedure room adjacent to the shock tube for the
length of the injured animals’ exposures [11].
Injured animals underwent the same procedures as their
respective sham group in addition to being exposed to 5 mild
blasts of varying pressures at a rate of 1 per 30min (blast no.
1: Mylar membrane gauge thickness=750 [average peak total
pressure: 15.54psi or ∼107.14kPa, total overpressure duration:
9.01ms]; blast no. 2: Mylar membrane gauge thickness=1400
[average peak total pressure: 19.41psi or ∼133.83kPa, total
overpressure duration: 10.60ms]; blast no. 3: Mylar membrane
gauge thickness=1000 [average peak total pressure: 17.78psi
or ∼122.59kPa, total overpressure duration: 9.22ms]; blast no.
4: Mylar membrane gauge thickness=750; blast no. 5: Mylar
membrane gauge thickness=1000). Blast injury was admin-
istered to rats (weight at injury: 320–360 g) while wearing
chest protection using a compressed air-driven shock tube as
described earlier in detail [11,17]. Mortalitywas approximately
8% (i.e., 1 rat). All animals were transported back to the USU
animal facility at the conclusion of the exposures.
2.3. Physiological parameters
Physiological parameters were measured non-invasively
under isoﬂurane anesthesia at baseline, immediately follow-
ing injury (×5 for injured rats), and 24h after blast (or sham)
exposure using theMouseOx® Pulse Oximeter adopted for rats
(Starr Life Sciences Corp., Oakmont, PA, USA) [10]. The selected
parameters included: (a) arterial oxygen saturation, a ratio of
oxyhemoglobin to total hemoglobin concentration in arterial
blood (normalO2 levels: 95–100%; lowO2 levels: <95%); (b) heart
rate, the number of heartbeats per min (reference range for
Sprague Dawley rats: 250–450 beats per min); (c) pulse disten-
tion: a measure of local blood ﬂow; (d) breath rate, the number
of breaths taken per min (reference range for Sprague Dawley
rats: 70–115 breaths per min).
2.4. Behavioral tests: open ﬁeldAll animals were tested at baseline and 24h post-injury (or
sham) using the open ﬁeld (OF) system, which measures nat-
urally occurring behaviors that are exhibited when an animal
explores and interacts with its surroundings [18]. Variablesi c s 3 ( 2 0 1 4 ) 22–37
extracted from the animal’s movement within the cham-
bers (i.e., horizontal movement, vertical movement, and time
spent in the center of the chamber) provide information about
gross motor performance, depression-related behavior, and
anxiety-related behavior.
OF activity was measured using the Accuscan Super-
ﬂex Sensor Version 2.2 infrared photocell system in the
Accuscan Instruments Standard Animal Cage (measuring
40× 40× 30 cm; Accuscan Instruments Incorporated, Colum-
bus, OH) located in a dedicated room designed to minimize
acoustic interruptions. The animal’s locomotion is captured
by three, paired 16-photocell Superﬂex Sensors that trans-
mit the location data to the Accuscan Superﬂex Node located
on the upper-rear of the chamber. The Superﬂex Node trans-
mits the OF data from each of the 16 chambers to a computer
located within the test room where the data is processed and
aggregated by the Accuscan Fusion Software (Version 3.4). The
OF activity of each rat was measured for 1h during its active
period (dark cycle).
2.5. Blood and tissue collection
Animals were terminated 1 day following the completion
of the behavioral testing (i.e., 48h post-injury or sham). For
protein measures, rats (N=14; naïve=4, sham=4, injured=6)
were deeply anesthetized with isoﬂurane inhalant until a
tail or toe pinch produced no reﬂex movement. Blood was
obtained by cardiac puncture, and samples were promptly
centrifuged at 10,000 rpm for 15min at 4 ◦C. The supernatants
(plasma) were aliquoted, ﬂash-frozen, and stored at −80 ◦C
until processing. Animals were then decapitated using a guil-
lotine (Harvard Apparatus Co.; Dover, MA) and the brains were
immediately removed. The prefrontal cortex (PFC), amygdala
(AD), ventral hippocampus (VHC), and dorsal hippocampus
(DHC) were dissected over wet ice and the dissected brain
regions were then ﬂash-frozen and stored at −80 ◦C until
processing [14,11].
2.6. Protein measures
Relative concentrations of the selected protein biomarkers
(Supplementary Table) were determined using RPPM. Sam-
ple preparation, printing, scanning, and data analysis were
performed as follows and as described earlier [14,15,19,20].
Dissected brain regions were pulverized in liquid nitrogen
using a mortar and pestle. Two hundred milligrams of the
powder were transferred into 1mL of Tissue-Protein Extrac-
tion Reagent (T-PER) lysis buffer (78510; Thermo Scientiﬁc,
Waltham, MA) with EDTA-free Halt Protease and Phosphatase
Inhibitor Cocktail (78441; Thermo Scientiﬁc) in 1.5mL tubes
on ice. The suspensions were kept on ice and sonicated in a
Misonix S-4000 automated sonicator (Misonix, Farmingdale,
NY) at an amplitude of 20 using 12 repeats of 10 s bursts with
50 s cooling breaks between bursts. Samples were then cen-
trifuged at 4 ◦C at 15,000× g for 15min and the supernatants
were aliquoted and stored at −80 ◦C until use. Tissue pro-
tein concentrations were measured using a bicinchoninic acid
(BCA) assay (PI-23250, Thermo Scientiﬁc).
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Tissue samples were thawed on ice and diluted in print
uffer to a ﬁnal protein concentration of 1mg/mL; 240g of
rotein (by corresponding volume) were mixed with 80L of
× print buffer (30% glycerol, 0.15% SDS, and 150mM DTT in
× TBS) and the ﬁnal volume was adjusted to 240L with
he appropriate amount of water (270733; Sigma Aldrich, St.
ouis, MO). Plasma samples were diluted 1:10 by volume;
4L of plasma, 80L of 3× print buffer, and 136L of water
for a ﬁnal volume of 240L. Individual samples were then
subjected to an 11-point serial 1:2 dilution in 96-well plates
using a JANUS Varispan Integrator and Expanded Platform
Workstation (PerkinElmer, Waltham, MA) and transferred into
384-well microarray plates (X7022; Molecular Devices, Sunny-
vale, CA). Plates were centrifuged at 4 ◦C at 1500× g for 5min
nd transferred into an Aushon 2470 Arrayer (Aushon Biosys-
ems, Billerica, MA) for printing.
Samples were printed on Grace Bio-Labs ONCYTE® NOVA
plasma; 505177) orAVID (tissue; 305177) single-padnitrocellu-
ose coated glass slides. The AushonArrayerwas programmed
o use 16 pins and set for a single deposition per dot for plasma
nd double for brain tissue. Each sample was printed in 12
ilutions (12 rows) and in triplicates (3 columns) resulting in a
lock of 3× 12 dots. The spot diameter was set to 250nm with
spacing of 500nm between dots on the x-axis and 375nm
n the y-axis. Wash time was set at 1.2 s for tissue and 2 s for
lasma without delays.
Primary antibodies were diluted in antibody incubation
uffer (0.1% BSA, EDTA-free Halt Protease and Phosphatase
nhibitor Cocktail, 1× TBS, 0.5% Tween-20) and used in the
ilutions listed (Supplementary Table). All antibodies were
retested for speciﬁcity by Western Blot analysis using tissue
xtracts (or plasma) along with a speciﬁc positive control [16].
he slideswere blockedwith 5%driedmilk in 1×TBSwith 0.1%
ween-20 (TBST). Two hundred L of the primary antibody
olution was then distributed over the entire nitrocellulose
urface of the slide, covered with a cover slip (Nunc* mSeries
ifterSlips, Fisher Scientiﬁc, Pittsburgh, PA), and incubated in a
umidity chamber at 4 ◦Covernightwhile being gently rotated.
he next day, slides were washed 3 times in 0.1% TBST for
0min each, and then incubated with the secondary anti-
odies Alexa Fluor® 633 donkey anti-sheep (A-21100), Alexa
luor® 635 goat anti-mouse (A-31574), Alexa Fluor® 647 goat
nti-rabbit (A-21245) or rabbit anti-goat IgG (A-21446) from
nvitrogen at a 1:6000 dilution in antibody incubation buffer
or 1h at room temperature. Slides were washed 3 times in
.1% TBST 10min each, and 1 time in 1× TBS. Slides were then
llowed to fully air dry in the dark.
The ﬂuorescent signals were measured by scanning the
lides in a Scan Array Express microarray scanner (Perkin
lmer, Waltham, MA). Data were imported into a Microsoft
xcel-based bioinformatics program developed in house for
nalysis [14–17]. The linear regression of the log–log data was
alculated after the removal of ﬂagged data, which include
ignal to noise ratios of <2, spot intensities in the saturation
r noise range, or high variability between duplicate spots
>10–15%). The total amount of antigen is determined by the
-axis intercept or Y-cept [16].cs 3 ( 2 0 1 4 ) 22–37 25
2.7. Data comparison and statistical analyses
All animals (N=21; naïve=4, sham=6, injured=11) were used
for the physiological and the behavioral analyses. Paired
t-tests were used to assess changes in arterial oxygen satura-
tion, heart rate, pulse distention, and breath rate within each
group (baseline vs. 24h); all post-injury values were compared
to baseline values in injured rats. To determine differences
(if any) in the measured physiological parameters among the
three groups, a one-way ANOVA followed by Tukey’s HSD test
was conducted at baseline and at 24h. ANOVA (covarying
for baseline) followed by Tukey’s HSD test were conducted
for each of the behavioral variables. OF activity scores were
separated into three subscales: horizontal activity, vertical
activity, and center time. Comparisons were performed for
Condition and Time, and statistically signiﬁcant differences
were reported where applicable.
Fourteen animals (naïve=4, sham=4, injured=6) were
used for the protein analyses. Differences in the mean protein
biomarker levels measured in plasma and in brain tissue were
analyzed with ANOVA followed by Tukey’s HSD test. Statistical
signiﬁcance was reported for naïve vs. injured and sham vs.
injured. For protein levels in the plasma, statistically signiﬁ-
cant differences are indicated in boldface. For protein levels in
the brain, a two sided p value of <0.05 is depicted by one special
character, p<0.01 by two, and p<0.001 by three. All statistical
analyses were performed using IBM SPSS Statistics 20 soft-
ware. Tests were two tailed using ˛=0.05; data are presented
as the mean±S.E.M.
3. Results
3.1. Oxygen saturation and heart rate are transiently
depressed following repeated mild blast sustained at short
intervals
A pulse oximeter was used to measure arterial O2 satura-
tion, heart rate, pulse distension, and breath rate at baseline,
after each blast exposure for injured rats, and 24h post-injury
(or sham). Of the four physiological parameters, only arterial
O2 saturation levels and heart rate changed considerably in
response to the injuries (Fig. 1A–D). Both arterial O2 satura-
tion and heart rate signiﬁcantly decreased in the injured rats
compared to baseline values. However, this depression was
transient as it was followed by a full recovery at 24h (Fig. 1A
and B). No signiﬁcant injury-induced changes were measured
in pulse distension after any of the exposures while changes
in breath rate were minimal and similarly transient (Fig. 1C
and D).
3.2. Repeated mild blast overpressure exposure
adversely affects motor activity and functional outcome
Using an open ﬁeld system we determined the effect of
repeated mild blast exposure on gross motor activity as
well as anxiety- and depression-related behavior. Fig. 2A
summarizes the amount of horizontal activity, an index of
general health and movement, at baseline and 24h following
injury (or sham). Twenty-four hours post-injury, shamanimals
26 translat ional proteomics 3 ( 2 0 1 4 ) 22–37
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Fig. 1 – Signiﬁcant albeit transient reductions in arterial oxygen saturation and heart rate were measured in injured rats. (A)
Arterial oxygen saturation levels (%), (B) heart rate (number of beats per min), (C) pulse distension (m), and (D) breath rate
(number of breaths per min) were obtained under isoﬂurane anesthesia at baseline, immediately following injury (×5 for
injured rats), and at 24h post-injury. Data are presented as the mean±S.E.M. $p<0.05 for sham pre- vs. post-injury values;
jury*p<0.05, **p<0.01, and ***p<0.01 for injured pre- vs. post-in
(8504.16± 901.74) were not signiﬁcantly different from naïve
animals (10,661.92± 1103.70), but therewas a signiﬁcant effect
of injury such that injured animals (6777.67± 665.50) had sig-
niﬁcantly less horizontal activity than naïve animals.
Fig. 2B shows the amount of vertical activity, an index of
depression-related behaviors, where less vertical activity indi-
cates more depression-related behaviors. At 24h post-injury,
sham animals (1288.55± 209.48) were not signiﬁcantly differ-
ent from naïve animals (1862.90± 256.25). However, injured
animals (887.01± 154.38) had signiﬁcantly less vertical activ-
ity than naïve animals. Injured animals (70.86± 22.44) also
spent signiﬁcantly less time in the center of the chamber, an
index of anxiety-related behaviors (more time in the center
indicates less anxiety-related behaviors), than naïve animals
(236.73± 36.37) (Fig. 2C). Naïve animals were not signiﬁcantly
different from sham animals (140.63± 30.12).
3.3. The exposure to mild blasts at short intervals
induces complex changes in protein biomarker levels in
functionally-relevant brain regionsTwo days following injury (or sham), we dissected the PFC,
AD, DHC, and VHC and determined the effect of repeated
mild blast exposure on tissue levels of select protein biomark-
ers related to oxidative stress and vascular functions, cellularvalues.
adhesion and the extracellularmatrix, inﬂammation, and glial
cell response.
Of the two biomarkers related to oxidative stress, 4-
hydroxy-2-noneal (HNE) and hypoxia-inducible factor 1
(HIF1), HNE was signiﬁcantly increased in all four of the
tested brain regions whereas changes in HIF1 tissue levels
were limited to the AD and the DHC of injured rats (Fig. 3A and
B). Similar to HNE, vascular endothelial growth factor (VEGF)
and aquaporin 4 (AQP4) levels were signiﬁcantly increased in
all brain regions of the injured rats. On the other hand, tissue
levels of von Willebrand factor (vWF) were most signiﬁcantly
changed in the PFC only (Fig. 3C–E).
We also detected signiﬁcant injury-induced changes in the
tissue levels of cellular adhesion and extracellular matrix
molecules. While integrin 6 tissue levels were mainly
elevated in the PFC and the AD of injured rats, TIMP
metallopeptidase inhibitor 1 (TIMP1) concentrations were sig-
niﬁcantly elevated in all brain regions but the DHC (Fig. 4A and
B). Of the two extracellular matrix proteins, only TIMP metal-
lopeptidase inhibitor 4 (TIMP4) was signiﬁcantly increased in
all of the tested brain regions compared to naïve and/or sham
animals (Fig. 4C).
Among the tested inﬂammatory biomarkers, only galectin-
1 (Gal-1) and macrophage inﬂammatory protein 1 (MIP1)
were signiﬁcantly higher in all four brain regions of exposed
translat ional proteomics 3 ( 2 0 1 4 ) 22–37 27
Fig. 2 – Injured rats exhibit a decline in gross movement and an elevation in depression- and anxiety-related behaviors. An
open ﬁeld system was used to measure (A) horizontal activity (number of beam breaks), (B) vertical activity (number of
beam breaks), and (C) center time (s) at baseline and 24h following blast (or sham) exposure. Data are presented as the
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ats (Figs. 4E and 5C, respectively). Matrix metalloproteinase
(MMP8) and chemokine (C–C motif) receptor 5 (CCR5) lev-
ls were signiﬁcantly elevated in all brain regions but the
D (Figs. 4D and 5D, respectively) while toll-like receptor
(TLR9), p38 mitogen-activated protein kinase (p38 MAPK),
nd osteopontin (OPN) tissue levels were elevated in all
rain regions but the DHC (Figs. 4F and 5A and B, respec-
ively).
Both microglia- and astroglia-speciﬁc markers (CD53
OX44) and glial ﬁbrillary acidic protein (GFAP), respectively)
howed signiﬁcant injury-induced increases in injured rats
ompared to naïve and/or sham animals. OX44 levels were
ncreased modestly in all brain regions but the AD (Fig. 5E).
y contrast, GFAP tissue levels increased in all of the analyzedbrain regions with the change being among the most robust
of the tested biomarkers (Fig. 5F).
3.4. Some of the molecular changes induced by
repeated, high frequency mild blast exposure are reﬂected
in altered plasma levels of protein biomarkers
Plasma levels of the three tested oxidative stress-related
markers, HNE, HIF1, and ceruloplasmin, and several vas-
cular protein biomarkers—VEGF, vWF, aquaporin 1 (AQP1),
AQP4, fetal liver kinase 1 (FLK1/VEGF receptor 2), and claudin
5—were signiﬁcantly increased in injured rats compared to
naïve, sham, or both control groups (Table 1). Plasma con-
centrations of cell adhesion and extracellular matrix proteins,
28 translat ional proteomics 3 ( 2 0 1 4 ) 22–37
Fig. 3 – Brain tissue levels of oxidative stress and vascular protein biomarkers in the selected brain regions. Tissue extracts
were prepared from the prefrontal cortex (PFC), amygdala (AD), dorsal and ventral hippocampus (DHC and VHC, respectively)
of naïve, sham, and injured rats. The reported Y-cept values (log10) indicate relative protein concentrations; data are
presented as the mean±S.E.M. *p<0.05 and **p<0.01 for naïve vs. injured; $p<0.05 and $$p<0.01 for sham vs. injured.
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Fig. 4 – Brain tissue levels of proteins related to cellular adhesion, extracellular matrix, and inﬂammation in the selected
brain regions. Tissue extracts were prepared from the prefrontal cortex (PFC), amygdala (AD), dorsal and ventral
hippocampus (DHC and VHC, respectively) of naïve, sham, and injured rats. The reported Y-cept values (log10) indicate
relative protein concentrations; data are presented as the mean±S.E.M. *p<0.05, **p<0.01, and ***p<0.001 for naïve vs.
injured; $p<0.05 and $$p<0.01 for sham vs. injured.
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Fig. 5 – Brain tissue levels of protein biomarkers related to inﬂammation and glial cell response in the selected brain
regions. Tissue extracts were prepared from the prefrontal cortex (PFC), amygdala (AD), dorsal and ventral hippocampus
(DHC and VHC, respectively) of naïve, sham, and injured rats. The reported Y-cept values (log10) indicate relative protein
concentrations; data are presented as the mean±S.E.M. *p<0.05, **p<0.01, and ***p<0.001 for naïve vs. injured; $p<0.05,
$$p<0.01, and $$$p<0.001 for sham vs. injured.
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Table 1 – Oxidative stress and vascular protein biomarker levels in the plasma.
Comparison of means
ANOVA Naïve vs. injured Sham vs. injured
Group Mean±S.E.M. F value p Value Mean diff. p Value Mean diff. p Value
HNE
Naïve 6.355 ± 0.12 12.769 0.0002 −0.508 0.0003 −0.399 0.0040
Sham 6.464 ± 0.08
Injured 6.863 ± 0.06
HIF1
Naïve 4.289 ± 0.30 6.303 0.0061 −0.986 0.0118 −0.878 0.0261
Sham 4.397 ± 0.21
Injured 5.275 ± 0.19
Ceruloplasmin
Naïve 6.469 ± 0.04 19.622 0.0001 −0.485 0.0001 −0.375 0.0004
Sham 6.579 ± 0.04
Injured 6.955 ± 0.07
VEGF
Naïve 5.793 ± 0.08 9.664 0.0008 −0.918 0.0042 −0.998 0.0029
Sham 5.713 ± 0.03
Injured 6.711 ± 0.23
vWF
Naïve 4.095 ± 0.14 6.014 0.0086 −0.684 0.0096 −0.539 0.0673
Sham 4.239 ± 0.12
Injured 4.779 ± 0.17
AQP1
Naïve 5.119 ± 0.26 6.050 0.0075 −0.902 0.0160 −0.851 0.0234
Sham 5.169 ± 0.25
Injured 6.021 ± 0.15
AQP4
Naïve 6.037 ± 0.05 12.450 0.0002 −0.413 0.0003 −0.335 0.0042
Sham 6.114 ± 0.06
Injured 6.450 ± 0.07
FLK1
Naïve 4.868 ± 0.17 8.117 0.0022 −0.745 0.0033 −0.576 0.0233
Sham 5.036 ± 0.08
Injured 5.612 ± 0.14
Claudin 5
Naïve 5.221 ± 0.12 11.453 0.0003 −0.797 0.0003 −0.482 0.0312
Sham 5.537 ± 0.07
Injured 6.018 ± 0.13
Mean protein values (log 10) measured in the plasma of naïve, sham, and injured rats. Signiﬁcant differences in protein biomarker levels are
indicated in boldface. For p values<0.0001, the minimum value is listed as p=0.0001.
Table 2 – Cell adhesion and extracellular matrix protein biomarker levels in the plasma.
Comparison of means
ANOVA Naïve vs. injured Sham vs. injured
Group Mean±S.E.M. F value p Value Mean diff. p Value Mean diff. p Value
Integrin 6
Naïve 4.209 ± 0.12 18.567 0.0001 −1.379 0.0003 −1.363 0.0001
Sham 4.224 ± 0.20
Injured 5.587 ± 0.19
TIMP1
Naïve 4.178 ± 0.18 9.777 0.0009 −1.439 0.0009 −1.043 0.0192
Sham 4.574 ± 0.25
Injured 5.617 ± 0.27
TIMP4
Naïve 4.650 ± 0.08 14.195 0.0001 −0.564 0.0002 −0.460 0.0022
Sham 4.753 ± 0.07
Injured 5.213 ± 0.09
, and
ted as
i
i
m
nMean protein values (log 10) measured in the plasma of naïve, sham
indicated in boldface. For p values<0.0001, the minimum value is lis
ntegrin 6, TIMP1, and TIMP4, were also signiﬁcantly elevated
n injured animals (Table 2).
Inﬂammatory markers Gal-1, p38 MAPK, MIP1, CCR5,
onocyte chemotactic protein 1 (MCP1), cytokine-induced
eutrophil chemoattractant 1 (CINC1), ﬁbrinogen,injured rats. Signiﬁcant differences in protein biomarker levels are
p=0.0001.
C-reactive protein (CRP), and N-formyl peptide receptor
(FPR) were signiﬁcantly increased in the plasma of injured
rats compared to naïve and/or sham animals (Table 3).
Consistent with the abovementioned biomarkers, plasma
concentrations of glial—GFAP, OX44, and S100 calciumbinding
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Table 3 – Inﬂammatory protein biomarker levels in the plasma.
Comparison of means
ANOVA Naïve vs. injured Sham vs. injured
Group Mean±S.E.M. F value p Value Mean diff. p Value Mean diff. p Value
Galectin
Naïve 5.079 ± 0.05 6.134 0.0068 −0.286 0.0404 −0.354 0.0101
Sham 5.011 ± 0.11
Injured 5.365 ± 0.07
p38 MAPK
Naïve 3.732 ± 0.39 8.502 0.0018 −1.396 0.0051 −1.317 0.0081
Sham 3.811 ± 0.29
Injured 5.128 ± 0.20
MIP1
Naïve 4.690 ± 0.16 4.513 0.0241 −0.371 0.0416 −0.353 0.0672
Sham 4.707 ± 0.09
Injured 5.060 ± 0.06
CCR5
Naïve 4.026 ± 0.20 5.170 0.0176 −0.896 0.0165 −0.586 0.1626
Sham 4.337 ± 0.13
Injured 4.922 ± 0.22
MCP1
Naïve 4.053 ± 0.09 6.449 0.0057 −0.552 0.0060 −0.387 0.0605
Sham 4.218 ± 0.11
Injured 4.605 ± 0.13
CINC1
Naïve 3.860 ± 0.06 37.765 0.0001 −1.224 0.0001 −1.337 0.0001
Sham 3.746 ± 0.11
Injured 5.083 ± 0.14
Fibrinogen
Naïve 4.840 ± 0.22 6.932 0.0046 −0.722 0.0073 −0.595 0.0377
Sham 4.968 ± 0.09
Injured 5.563 ± 0.13
CRP
Naïve 5.154 ± 0.17 3.864 0.0357 −0.474 0.0395 −0.362 0.1559
Sham 5.266 ± 0.08
Injured 5.628 ± 0.12
FPR
Naïve 4.831 ± 0.31 4.166 0.0381 −0.498 0.4472 −0.917 0.0310
Sham 4.412 ± 0.36
Injured 5.329 ± 0.08
, and
ted asMean protein values (log 10) measured in the plasma of naïve, sham
indicated in boldface. For p values<0.0001, the minimum value is lis
protein  (S100)—and neuronal protein markers—neuron-
speciﬁc enolase (NSE), neuroﬁlament-heavy chain (NF-H),
creatine kinase-brain type (CK-BB), and tau—were all signif-
icantly elevated in the injured animals two days after blast
overpressure exposure (Table 4).
4. Discussion
In this work we have shown that mild blast overpressure
repeated at the rate of 1 per 30min causes signiﬁcant phys-
iological, neurobehavioral, and molecular changes using our
well-established rat model of bTBI. Our ﬁndings suggest that
oxidative stress, vascular pathologies, and inﬂammation are
critical components of the molecular pathology underlying
ICV in blast-induced rmTBI. The biomarkers used in this study
are candidates for clinical testing and if veriﬁed, they can be
developed into blood-based diagnostics to aid in the identiﬁ-
cation of individuals with ICV.
We selected to monitor changes in physiological param-
eters using non-invasive methods similar to those utilized
in clinical settings. Injury-induced changes in heart and
respiratory rates, O2 arterial saturation, and pulse distention
are used as indicators of potential intracerebral pathologiesinjured rats. Signiﬁcant differences in protein biomarker levels are
p=0.0001.
such as disturbed cerebral blood ﬂow, elevated intracranial
pressure, and ischemia especially in severe and moderate
TBI. These transient post-injury changes, particularly post-
traumatic hypoxia, can contribute to ICV. We found that while
heart rate remained within the normal range for rats, it was
signiﬁcantly decreased after mild blast overpressure expo-
sure compared to baseline. Similarly, arterial O2 saturation
was signiﬁcantly lower after exposures compared to pre-
injury values. The mild and transient hypoxia we measured
is consistentwith previous observations identifyingmetabolic
depression as one of the underlying causes of ICV. Thus, itmay
be useful tomonitor vital signs as they can aid in the detection
of altered physiology and the degree of ICV.
Behavioral assessments have shown that mood changes
and increased anxiety are two of the major symptoms fol-
lowing bTBI [21,22]. We previously observed such changes
when we exposed rats to a single or multiple mild blasts
24h apart and found that anxiety- and depression-related
changes manifest shortly after injury and are transient in
nature [11]. However, we failed to detect a cumulative effect
of repeated blast (and consequently more severe behavioral
symptoms) in multiple-injured rats relative to single-injured
rats at that “low” blast frequency. In our current study, we also
found signiﬁcantly increased anxiety- and depression-related
translat ional proteomics 3 ( 2 0 1 4 ) 22–37 33
Table 4 – Glial and neuronal protein biomarker levels in the plasma.
Comparison of means
ANOVA Naïve vs. injured Sham vs. injured
Group Mean±S.E.M. F value p Value Mean diff. p Value Mean diff. p Value
GFAP
Naïve 4.725 ± 0.11 8.785 0.0014 −0.556 0.0102 −0.673 0.0029
Sham 4.608 ± 0.13
Injured 5.281 ± 0.13
CD53 (OX44)
Naïve 4.612 ± 0.21 3.787 0.0366 −0.411 0.1801 −0.587 0.0383
Sham 4.436 ± 0.16
Injured 5.024 ± 0.12
S100
Naïve 4.163 ± 0.11 68.988 0.0001 −1.264 0.0001 −1.460 0.0001
Sham 3.967 ± 0.08
Injured 5.428 ± 0.10
NSE
Naïve 3.541 ± 0.09 26.101 0.0001 −1.129 0.0001 −1.076 0.0001
Sham 3.594 ± 0.06
Injured 4.670 ± 0.15
NF-H
Naïve 5.732 ± 0.05 6.310 0.0063 −0.196 0.0329 −0.241 0.0110
Sham 5.687 ± 0.05
Injured 5.928 ± 0.05
CK-BB
Naïve 4.342 ± 0.14 6.930 0.0040 −0.568 0.0072 −0.484 0.0229
Sham 4.426 ± 0.11
Injured 4.910 ± 0.11
Tau
Naïve 4.454 ± 0.14 30.884 0.0001 −1.635 0.0001 −1.549 0.0004
Sham 4.540 ± 0.27
Injured 6.089 ± 0.15
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ehaviors in injured animals but no conclusions can be made
bout the role of ICV in the cumulative effect of repeated mild
last exposure due to the absence of a 24h interval blast group.
he only other study assessing the effects of “tightly coupled”
ild blast exposures using the rotarod test showed a moder-
te, albeit transient cumulative effect of multiple exposures
here animals gradually recovered starting at day 5 post-
njury [23]. Unfortunately, no behavioral assessments were
erformed in the two key studies that directly address the
nvolvement of metabolic depression and axonal and vascu-
ar changes in ICV [6,8], although a previous work by the same
roup has shown increased cognitive deﬁcits after repeated
BI [7].
Clinical observations have indicated that the behavioral
ymptoms of mTBIs partly overlap with those of post-
raumatic stress disorder (PTSD) [21]. However, available
xperimental data indicate that the molecular pathologies
f PTSD and bTBI may be distinct [14,24,25]. The observed
ncrease in anxiety indicates that the prefrontal cortex and/or
ts functionally related structures (the amygdala and the
ippocampus) are adversely affected by repeated injury.
xperimental research and clinical imaging studies have
hown that the PFC is involved in mediating symptoms
ssociated with PTSD as well as TBI, and that the PFC is espe-
ially susceptible to noxious insults including trauma [26–29].
ccordingly, our proteomics analyses of the PFC, AD, DHC and
HC showed that of the 17 protein biomarkers measured in
rain tissue, the expression of 16 changed signiﬁcantly in the
FC of injured rats. The second most affected brain region wasinjured rats. Signiﬁcant differences in protein biomarker levels are
p=0.0001.
the VHC in which 14 of the 17 markers changed signiﬁcantly
in response to repeated injury followed by the AD (13 markers)
and the DHC (11 markers).
The detected changes in tissue levels of the measured
markers suggest complex pathological processes as a result
of repeated blast overpressure exposure. This includes oxida-
tive stress, which can be related to and/or triggered by the
relative hypoxia as discussed above. HNE, a byproduct of
lipid peroxidation [30,31], was signiﬁcantly elevated in all four
brain regions of injured rats. Interestingly, HIF1was the only
marker with unchanged tissue levels in the PFC in response
to repeated injury although its levels were signiﬁcantly ele-
vated in the AD and in the DHC. HIF1, a transcription factor,
is part of the adaptive and restorative cellular mechanisms
that followvariousnoxiousneuronal insults involvinghypoxia
(e.g., TBI and stroke) [32]. A potential explanation for why
HIF1 levels remained unchanged in the PFC is the relatively
early activation of HIF1 in response to hypoxia, which is
within hours and thus outside of our current termination time
point (2 days).
Tissue levels of the three markers associated with various
aspects of vascular function were signiﬁcantly elevated in the
PFC of injured animals. These ﬁndings are consistent with
previous observations implicating altered vascular function
in the period of ICV. Using impact acceleration injury, Fujita
et al. (2012) demonstrated that the initial mild insult can
result in ICV via vascular hypersensitivity [6]. When the
injury was repeated within 3h of the initial insult, the second
mild injury triggered vascular dysfunction as measured by
teom34 translat ional pro
the hypersensitivity of brain vasculature to acetylcholine
stimulation. No such hypersensitivity was detected when
re-injury took place 10h after the initial injury.
In our study, we found that the expression of VEGF, a
mediator of multiple endothelial functions including vascular
permeability and endothelial proliferation [33,34], increased
signiﬁcantly in all tested brain regions. Similar to VEGF, AQP4
was elevated in all four regions. Increased tissue levels of
AQP4, a main water channel of the central nervous sys-
tem (CNS) [35,36], indicate altered blood brain barrier (BBB)
function. Brain edema has been observed after various brain
insults including subarachnoid hemorrhage and TBI. The sig-
niﬁcance of altered BBB permeability following blast-induced
rmTBI is currently not known, but increased BBB permeabil-
ity has been demonstrated after repeated mild athletic TBI. Of
the three vascular markers, vWF tissue levels were only sig-
niﬁcantly elevated in the PFC. In addition to its major role in
regulating blood coagulation, vWF has additional functions in
the inﬂammatory response to vascular damage [37].
Neuroinﬂammation, a hallmark of TBI, can be triggered
by multiple upstream pathological changes such as vascular
damage and altered cellular adhesion [38,39]. Abnormal cell
surface interactions and the activation of various extracel-
lular matrix proteins have been found after CNS injury [40].
The involvement of the extracellular matrix in the pathobiol-
ogy of blast-induced rmTBI is indicated by the brain region
speciﬁc increase in integrin 6. As a member of the trans-
membrane receptor family, integrin 6 plays a vital role in cell
adhesion and cell–cell interactions as well as signal transduc-
tion from the extracellular milieu into the cell [41]. The role of
the extracellular matrix in ICV is further demonstrated by the
substantial increase in brain tissue levels of TIMP1 and TIMP4,
inhibitors of matrix metalloproteinases [42,43]. The expres-
sion of TIMP1 and TIMP4 in the PFC as well as the AD (and to a
lesser extent in thehippocampal sub-regions) is inducedat the
transcriptional level by several cytokines linking cell surface
remodeling to inﬂammation.
The selected markers perform various functions in the
inﬂammatory process. Consistent with altered TIMP1 and
TIMP4 expression, we found elevated tissue levels of MMP8,
a matrix metalloproteinase involved in tissue remodeling
after injury and chemokine/cytokine activation and inactiva-
tion [44]. Gal-1, a -galactoside-binding protein with intra-
and extracellular functions, is heavily involved in the initi-
ation, propagation, and overall mediation of inﬂammatory
processes [45]. Gal-1 overexpression in the PFC of injured
animals is indicative of pathological progression in this vul-
nerable region. Another molecule with a role in the initiation
of the neuroinﬂammatory process is TLR9, a member of the
toll-like receptor family [46,47]. Cytokine signaling by the TLRs
and other proteins activates p38 MAPK in the injured tissues.
Both TLR9 and p38 MAPK were similarly elevated in the PFC,
the AD, and the VHC.
OPN plays a number of roles in immune function that
include cytokine production, cell attachment, and cell acti-
vation [48]. Another molecule involved in the synthesis
and the delivery of pro-inﬂammatory cytokines is MIP1,
a member of the Macrophage Inﬂammatory Protein family
of pro-inﬂammatory chemokines [38,39,49–52]. MIP1 medi-
ates immune response by activating inﬂammatory cells thati c s 3 ( 2 0 1 4 ) 22–37
release additional pro-inﬂammatory cytokines such as IL-1,
IL-6, and TNF- [53,54]. Chronically elevated MIP1 levels are
found in immune disorders of the CNS such as multiple scle-
rosis. In the injured CNS, MIP1 and OPN are likely produced
by microglia, the resident immune cell of the brain [55,56].
CCR5 is a receptor for various chemokines including MIP1,
MIP1, andRANTES [57]. Changes in brain tissue levels of CCR5
in response to repeated blast injury were similar to those of
MMP8 as it was signiﬁcantly elevated in the PFC and the two
hippocampal sub-compartments but not in the AD. CCR5, a
G-protein coupled receptor, is also expressed by macrophages
and by other cells with signaling functions between the ner-
vous and immune systems [53,58].
CD53 is a marker of microglia and macrophages [52]. While
it is possible that there was a macrophage response at this
level of repeated injury, we cannot conﬁrm this in the absence
of a detailed immunohistochemical analysis. Nonetheless,
we detected signiﬁcantly increased CD53 (OX44) levels in all
brain regions but the AD. Another cell type involved in the
neuroinﬂammatory process is the astrocyte marked by GFAP
expression [59]. Tissue levels of GFAP were signiﬁcantly ele-
vated in all brain regions of injured animals. However, the
change in GFAP levels was the most robust suggesting that
astroglial response (i.e., gliosis) is amore global response in the
injured brain than some of the markers we as well as others
have analyzed. This global glial response to injury is consistent
with the numerous and somewhat diverse functions astroglia
play in the normal and injured CNS [60–64].
Of the markers related to metabolic changes/oxidative
stress and vascular functions, only vWF levels were not sig-
niﬁcantly increased in injured rats relative to their sham
counterparts. This ﬁnding is in contrast with the signiﬁcant
increases in vWF levels in the PFC of injured rats compared
to both naïve and sham animals. However, this supports
our previous ﬁndings that experimental manipulations alone
(i.e., sham conditions) can trigger pathological changes due
to the role of stress as a cofactor in bTBI [14,17]. These
ﬁndings also suggest that some of the changes can be spa-
tially/anatomically restricted andmight not be reﬂected in the
systemic circulation. This notion is supported by the ﬁnding
that plasma levels of several inﬂammatory markers (MIP1,
CCR5, MCP1 and CRP) were unchanged while there were sig-
niﬁcant changes in their tissue levels, again mostly in the PFC.
As discussed above, these markers are involved in mediating
the injury process at various levels.
Elevated plasma levels of the measured cell surface mark-
ers (integrin 6, TIMP1 and TIMP4) are likely indicative of the
increases measured in brain tissue [43,65–67]; these markers
can also be of extracellular origin. All brain-speciﬁc proteins
were signiﬁcantly elevated in the plasma of injured animals
relative to sham animals. The increases in neuronal and glial
markers suggest complex neuropathologies that include glial
loss/damage as indicated by elevated GFAP and S100 levels.
The correlation between elevated serum levels of GFAP and
S100 and injury severity and outcome have been extensively
studied in experimental and in clinical TBI [68–71]. Elevated
levels of S100 are frequently found during the acute phase of
TBI [71]. However, this early increase can be (and typically is)
of extracranial origin because damage to other organs results
in increased levels of circulating S100. Consistent with most
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linical studies, we found no correlation between injury sever-
ty and S100 plasma levels in our earlier experimental work
15]. Nevertheless, a recent article showed that the temporal
attern of circulating S100 correlates very well with injury
utcome if patients are monitored for an extended period
f time [72]. While increased serum levels of GFAP have a
imited prognostic value alone, they can provide a signiﬁ-
ant predictive value in combination with other markers such
s microtubule-associated protein 2 (MAP2) [73], ubiquitin C-
erminal hydrolase L1 (UCH-L1), and II-spectrin breakdown
roduct (SBDP145) [74].
Similar to GFAP and S100, NSE, NF-H and CK-BB have
been extensively tested in different TBI studies [75–77]. These
markers have also been tested in clinical studies with vary-
ing extents of correlation between measured sera levels and
injury severity and/or outcome. Increased plasma levels of
these proteins reﬂect neuronal damage and/or loss. However,
elevated serum NSE levels have been previously detected after
extracranial insults such as cardiac arrest [78,79]. Our earlier
work using the porcine model of bTBI has showed that the
temporal proﬁle of serum NF-H levels correlates with injury
severity [15]. One of the most substantive increases in plasma
biomarker levelswas of tauprotein, indicating axonal damage.
This ﬁnding may be especially signiﬁcant since tau patholo-
gies have been suspected to play a key role in the development
of chronic neurodegenerative conditions (e.g., chronic trau-
matic encephalopathy) following rmTBI [80–85].
In summary, we found that: (1) ICV in the rodent model
of blast-induced rmTBI is measured in hours, which roughly
translates to days in humans. (2) A number of complex molec-
ular pathologies contribute to ICV in blast-induced rmTBI;
these include metabolic changes/oxidative stress, vascular
dysfunction, altered cellular adhesion and interaction, inﬂam-
mation, as well as neuronal and glial damage and/or loss. (3)
Virtually all of the molecular pathologies affected the PFC,
which may potentially account for the increased anxiety- and
depression-related behaviors exhibited by injured rats; this
observation maybe related to the PFC’s anatomical localiza-
tion and vulnerability to physical injuries, especially if they
are repetitive in nature. (4) These pathologies are also reﬂected
in altered plasma levels of biomarkers that can be validated
in humans and developed into blood-based diagnostics for
the purpose of identifying individuals with ICV. A limita-
tion of our current study is that injury-induced changes in
marker plasma levels were determined at a single, terminal
time point. Accordingly, serial blood sampling would provide
invaluable information about the temporal pattern of molec-
ular changes that may be critical for the identiﬁcation of the
period of ICV in rmTBIs.
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